Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04556253
What this trial is testing

AK104 in Locally Advanced MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer

Who this might be right for
MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer
Peking University 47
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)UnknownNCT06239870
What this trial is testing

Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer

Who this might be right for
Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer
Yunnan Cancer Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00103142
What this trial is testing

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Michael Morse, MD 74
Not applicableStudy completedNCT02110329
What this trial is testing

Simultaneaous Detection of Quantitative Somatic Alterations Using the Qantitative Multiplex Pcr of Short Fluorescent Fragments Method (QMPSF) in Stage II-III Colon Cancer: a Prospective Study

Who this might be right for
Colorectal CancerStage II and III
University Hospital, Rouen 401
Testing effectiveness (Phase 2)Study completedNCT00107861
What this trial is testing

Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases

Who this might be right for
Colorectal CarcinomaMetastases
Biogen 44
Not applicableUnknownNCT02546596
What this trial is testing

The Effect of Electro-Hyperthermia in Preoperative Radiotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerHyperthermia
Yonsei Hyperthermia Study Group 76
Testing effectiveness (Phase 2)Ended earlyNCT00216086
What this trial is testing

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Gabi Chiorean, MD 22
Testing effectiveness (Phase 2)Study completedNCT01386242
What this trial is testing

Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 108
Testing effectiveness (Phase 2)UnknownNCT00408551
What this trial is testing

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Goshen Health System 20
Testing effectiveness (Phase 2)UnknownNCT05160727
What this trial is testing

Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer

Who this might be right for
Mismatch Repair-proficientColorectal Cancer MetastaticMicrosatellite Stable
Zhejiang Cancer Hospital 44
Testing effectiveness (Phase 2)WithdrawnNCT02287727
What this trial is testing

Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment

Who this might be right for
Rectal AdenocarcinomaStage IIA Rectal CancerStage IIB Rectal Cancer+3 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT05839470
What this trial is testing

Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fujian Cancer Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05253846
What this trial is testing

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

Who this might be right for
Locally Advanced Rectal Cancer
Gruppo Oncologico del Nord-Ovest 63
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06936527
What this trial is testing

XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation

Who this might be right for
Colorectal CancerMetastatic Colorectal Cancer With RAS Mutation
NovaOnco Therapeutics Co., Ltd. 102
Testing effectiveness (Phase 2)Study completedNCT00940303
What this trial is testing

OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 97
Testing effectiveness (Phase 2)Active Not RecruitingNCT01815359
What this trial is testing

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

Who this might be right for
Appendix CancerColorectal Cancer
Memorial Sloan Kettering Cancer Center 292
Large-scale testing (Phase 3)Looking for participantsNCT06794086
What this trial is testing

SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
Jun Huang 24
Testing effectiveness (Phase 2)Looking for participantsNCT07047560
What this trial is testing

Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study

Who this might be right for
Colorectal Cancer (CRC)
Tianjin Medical University Cancer Institute and Hospital 46
Testing effectiveness (Phase 2)WithdrawnNCT00766220
What this trial is testing

Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver

Who this might be right for
Colon CancerColorectal Cancer
M.D. Anderson Cancer Center
Next Page